TickerHumSide-by-side comparison
Eli Lilly and vs Merck & Co.
As of Nov 11, 2026, P/E is 46.4x for Eli Lilly and vs 147.9x for Merck & Co.; P/S is 15.6x for Eli Lilly and vs 5.4x for Merck & Co.; revenue growth is 45.5% for Eli Lilly and vs 4.9% for Merck & Co.; net margin is 31.9% for Eli Lilly and vs 3.6% for Merck & Co..
What stands out
- Eli Lilly and is growing revenue faster: 45.5% vs 4.9% for Merck & Co..
- Eli Lilly and is cheaper on earnings: 46.4x P/E vs 147.9x for Merck & Co..
- Merck & Co.'s shares did better over the past year: +60.1% vs +40.6% for Eli Lilly and.
- Eli Lilly and scores higher on TickerHum's ratings: 70/100 vs 50/100 for Merck & Co..
Key metrics
| Metric | LLY | MRK |
|---|---|---|
| Price | $1,430.94 | $146.45 |
| Market cap | $1.35T | $361.04B |
| P/E | 46.4x (#1) | 147.9x (#2) |
| P/S | 15.6x (#2) | 5.4x (#1) |
| Revenue growth | 45.5% (#1) | 4.9% (#2) |
| Operating margin | — | — |
| Net margin | 31.9% (#1) | 3.6% (#2) |
| Debt / equity | 1.17 (#2) | 1.11 (#1) |
| 1-year return | +40.6% (#2) | +60.1% (#1) |
| Research score | 70/100 (#1) | 50/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Eli Lilly and Company (LLY) — Drug Manufacturers—General
- Merck & Co., Inc. (MRK) — Drug Manufacturers—General